Differential Drug Survival of Second-Line Biologic Therapies in Patients with Psoriasis: Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR). (2018)

First Author: Iskandar IYK
Attributed to:  MICA: Psoriasis Stratification to Optimise Relevant Therapy (PSORT) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jid.2017.09.044

PubMed Identifier: 29080680

Publication URI: http://europepmc.org/abstract/MED/29080680

Type: Journal Article/Review

Volume: 138

Parent Publication: The Journal of investigative dermatology

Issue: 4

ISSN: 0022-202X